Scientific Studies Explore Skin's Role in Allergic Diseases and Immune Balance

The skin is not merely a protective outer layer covering the body; it is a living organ with extensive influence that can sometimes reveal internal health issues before symptoms arise. Conditions such as rashes, dryness, itching, and inflammation are not always superficial signs but may serve as early indicators of immune system disturbances or imbalances in the microorganisms residing on the skin's surface.

Serving as the body's primary defense, the skin not only blocks pathogens and irritants but also regulates immune responses and interacts continuously with millions of microorganisms in a complex ecosystem known as the skin microbiome. The question arises: what occurs when this balance is disrupted, and can some allergic diseases originate in the skin before affecting the respiratory or digestive systems?

Understanding the Atopic March in Allergic Diseases

The term "Atopic March" describes a progression of allergic diseases that often begin in infancy and extend into later childhood. These conditions share genetic, environmental, and immunological factors, typically manifesting first as atopic dermatitis or eczema, followed by food allergies, asthma, and allergic rhinitis.

Introduced in dermatology in 1923 by American allergists A.F. Coca and R.A. Cooke, the concept of the Atopic March has been associated with atopy—the body's predisposition to develop allergic reactions, particularly those involving Immunoglobulin E (IgE). Over time, the definition expanded to include allergic diseases not solely mediated by IgE.

Statistics indicate that atopic dermatitis is among the most common allergic skin diseases, affecting between 17% and 24% of children and approximately 10% of adults worldwide. Early onset and severity of eczema are significant because they may correlate with an increased likelihood of developing other allergic conditions later. More than 60% of children with severe eczema also suffer from asthma, and between 74% and 81% experience allergic rhinitis, suggesting eczema can be the initial phase in a broader spectrum of immune and allergic disorders.

From Sequential Progression to Multiple Allergic Conditions

Historically, atopic dermatitis was viewed as an external manifestation of an underlying internal allergy. However, recent evidence supports a different perspective: eczema may primarily arise from intrinsic skin barrier defects, compounded by environmental factors and genetic susceptibility.

Advancements in technology, including artificial intelligence and machine learning applied to medical data analysis, have led researchers to move beyond the linear Atopic March model. Instead, the concept of "atopic multimorbidity" has emerged, recognizing that individuals may simultaneously or non-sequentially develop multiple allergic diseases due to skin barrier damage or microbiome imbalance.

Thus, the focus shifts from identifying which disease appears first to understanding the shared factors that enable the coexistence of these conditions. A significant portion of these factors relates to skin health and the equilibrium of its microbial inhabitants.

The Skin Microbiome and Its Role in Maintaining Balance

The skin hosts a diverse community of microorganisms, including bacteria, fungi, viruses, and microscopic parasites, collectively called the skin microbiota. The combined genetic material and interactions of these organisms constitute the skin microbiome.

Bacteria dominate this ecosystem, with over 1,000 species identified. These microbes are not randomly distributed but perform vital defensive and immune functions, such as preventing harmful bacteria from dominating, supporting the skin barrier, and modulating immune responses.

The colonization of the skin microbiota begins at birth and evolves throughout life, influenced by factors like delivery mode. Vaginally delivered infants acquire different microbial species, such as Lactobacillus and Prevotella, compared to those born via cesarean section, who obtain microbes more typical of skin flora.

The microbiome's distribution varies across skin regions; moist areas like the armpits differ from dry or oily zones. For example, Staphylococcus aureus is more prevalent in moist regions, while Proteobacteria dominate drier areas. Fungi, particularly lipid-loving Malassezia species, appear later on the skin, alongside bacteriophages—viruses that infect bacteria and contribute to microbial diversity. Other microscopic organisms, such as Demodex mites, interact with bacteria and fungi, making the skin a dynamic environment that maintains a delicate balance between health and disease.

How the Microbiome Protects the Skin

The skin microbiome performs multiple defensive roles. It combats opportunistic pathogens by limiting their growth through the production of antimicrobial substances, including antibacterial peptides and fatty acids.

Beyond pathogen suppression, the microbiome regulates the immune system by stimulating keratinocytes—the primary cells of the skin's outer layer—to release immune molecules like interleukin 1 alpha (IL-1α), defensins, and cathelicidins. These molecules help modulate T-cell responses and enhance the immune system's ability to tolerate beneficial microbes, thereby reducing irritation and inflammation and preserving skin stability.

From Eczema to Systemic Diseases

Disruptions in the skin microbiome have been linked to several skin diseases such as eczema and psoriasis. Recent research extends this association to systemic conditions including diabetes, inflammatory bowel disease, and obesity.

Some scientists explain these links through the gut-skin or brain-skin axes, indicating that the skin interacts with other body systems via immune responses, inflammation, and biochemical signaling.

In 2023, researchers from the University of California San Diego published a comprehensive review in the journal Frontiers, highlighting the skin microbiome's role in skin health and disease development. The review concluded that various exposures can alter the microbiome's composition, allowing certain Staphylococcus species to proliferate, which compromises the skin barrier and overall skin health.

Key factors influencing this balance include personal hygiene habits, skincare routines, frequent use of cosmetic products, and ongoing environmental exposures like sunlight, water, and temperature fluctuations.

The review emphasized that shifts in microbial interactions can trigger a cascade of changes leading to dysbiosis and skin disease. However, it also noted the complexity of cause-and-effect relationships, as it remains unclear whether microbiome imbalance precedes disease onset or results from it. Additionally, methodological differences in sampling and analysis limit some study conclusions, underscoring the need for further investigation.

Does Microbiome Imbalance Precede Atopic Dermatitis?

A 2025 review published in the journal Molecules by Polish researchers found that skin barrier weakness caused by imbalanced bacterial strains can exacerbate allergic inflammation. The review suggested that symptom relief might be linked to restoring the natural microbiome balance, supporting the idea that the microbiome plays a crucial protective role against allergens, particularly in atopic dermatitis cases.

Nonetheless, the authors cautioned that these findings are not definitive and called for additional clinical trials. They highlighted limitations such as insufficient strain-level microbial analyses and reliance on short-term studies, which constrain the generalizability of results.

Similarly, a 2025 study in Biomedicine & Pharmacotherapy, led by Indian researchers, supported the hypothesis that microbiome disruption may sometimes precede eczema development. The study noted that skin dryness or the use of topical antiseptics and antibiotics can inhibit beneficial bacteria growth, creating conditions favorable for opportunistic bacteria like Staphylococcus aureus and Staphylococcus caprae.

Importantly, these microbial changes can occur very early in life, before eczema symptoms become apparent, suggesting that microbiome imbalance may not just be a consequence but also a trigger for irritation and inflammation in some atopic dermatitis cases.

However, the study also acknowledged that the absence of standardized methodologies, technical biases in analysis, and limitations of experimental models restrict understanding of causality and the translation of findings into clinical practice.

Current Knowledge on Skin Health and Disease

In 2024, South Korean researchers published a review in the Journal of Bacteriology and Virology affirming that the skin microbiome is fundamental to maintaining skin and overall bodily health. The review linked microbiome imbalance and dominance of certain microbial species to a range of allergic skin diseases, with potential extension to systemic illnesses through complex interactions among the microbiome, immune system, and environmental factors.

However, the researchers emphasized that the critical question remains unresolved: whether skin barrier dysfunction and its microbial inhabitants cause skin diseases or result from them. This relationship may vary depending on the specific disease, individual genetics, environment, age, and lifestyle.

Given the intricate interplay among skin, microbiome, immunity, and environment, traditional investigative tools alone are insufficient to fully understand these dynamics. Multiple studies recommend employing artificial intelligence and machine learning to analyze subtle microbiome changes and correlate them with health and disease stages.

Such technologies could potentially forecast individuals’ susceptibility to eczema, allergies, or asthma and guide the development of targeted therapies aimed at restoring microbiome balance before disease onset or progression.

Despite these advances, the field is still in its early stages. Most research underscores the necessity for long-term clinical trials and more precise experimental models using standardized sampling and analytical techniques to move from scientific observation to clear medical recommendations.